Compare
Biodesix Inc vs Personalis, Inc. vs Exagen Inc. vs American Shared Hospital Services
| Latest fiscal year | Biodesix Inc BDSX | Personalis, Inc. PSNL | Exagen Inc. XGN | American Shared Hospital Services AMS |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $88.50M | $69.65M | $66.58M | $28.08M |
| Revenue growth (YoY) | +24.1% | -17.7% | +19.7% | -0.9% |
| Gross margin | n/a | 22.7% (computed) | 58.3% | 18.0% |
| Operating margin | -31.5% | -126.4% | -21.1% | -12.8% |
| Net margin | -39.8% | -116.7% | -30.0% | -5.5% |
| Net income | -$35.27M | -$81.27M | -$19.95M | -$1.55M |
| EPS (Diluted) | -$4.67 | -$0.91 | -$0.93 | -$0.23 |
| Operating cash flow | -$23.27M | -$74.95M | -$13.62M | $3.10M |
| Free cash flow | -$23.53M | -$79.45M | -$14.27M | -$4.54M |
| Cash & equivalents | $18.99M | $124.25M | $32.22M | $3.46M |
| Total assets | $87.48M | $334.16M | $58.02M | $55.48M |
| Total liabilities | $89.94M | $72.98M | $40.57M | $27.79M |
| Shareholders' equity | -$2.46M | $261.19M | $17.45M | $27.69M |
| Return on year-end equity | n/a | -31.1% | -114.3% | -5.6% |
| Shares outstanding | 8.25M | 102.48M | 22.91M | 6.58M |
Revenue, most recent five fiscal years
| Fiscal year | Biodesix Inc | Personalis, Inc. | Exagen Inc. | American Shared Hospital Services |
|---|---|---|---|---|
| Latest | $88.50M Ended 2025-12-31 | $69.65M Ended 2025-12-31 | $66.58M Ended 2025-12-31 | $28.08M Ended 2025-12-31 |
| 1 year earlier | $71.32M Ended 2024-12-31 | $84.61M Ended 2024-12-31 | $55.64M Ended 2024-12-31 | $28.34M Ended 2024-12-31 |
| 2 years earlier | $49.09M Ended 2023-12-31 | $73.48M Ended 2023-12-31 | $52.55M Ended 2023-12-31 | $21.32M Ended 2023-12-31 |
| 3 years earlier | $38.21M Ended 2022-12-31 | $65.05M Ended 2022-12-31 | $45.56M Ended 2022-12-31 | $19.75M Ended 2022-12-31 |
| 4 years earlier | $54.51M Ended 2021-12-31 | $85.49M Ended 2021-12-31 | $48.30M Ended 2021-12-31 | $17.63M Ended 2021-12-31 |